Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Oregon's Corporate Ownership Law Puts PE At Crossroads No Photo Available

Yeji Jesse Lee

A new law in Oregon is leaving private equity firms and other organizations at a crossroads as they try to figure out how to navigate ... (more story)

Trump's Abortion Guidance U-Turn Sparks Legal Risks No Photo Available

Mark Payne

Now that the Trump administration has pulled guidance telling doctors they must perform abortions in emergency situations, healthcare ... (more story)

'A Warning Shot?' Experts Eye Surge In Drug Ad Enforcement No Photo Available

Dan McKay

Despite its recent staff cuts and leadership changes, the U.S. Food and Drug Administration has launched a burst of enforcement activi... (more story)